TNF and Sepsis: Despite the failure of numerous clinical trials, some promise likely still exists in using anti-inflammatory treatment strategies in the early hours after the onset of sepsis such as IL-1 receptor blockade or anti-TNF treatments based on the identification of those that could survive from anti-inflammatory therapies in combination with antibiotics and resuscitation (152, 153).